Thomas Bärnthaler

7PUBLICATIONS
37CO-AUTHORS
AllergyMetabolic medicineDisease surveillanceCardiology (incl. cardiovascular diseases)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 07, 2026
Brepocitinib, a selective TYK2/JAK1 inhibitor, mitigates neutrophilic inflammation and glucocorticoid receptor-β expression in COPD.

Barsha Baisakhi Nayak, Thomas Bärnthaler, Rishi Rajesh

|Mar 27, 2025
Succinate aggravates pulmonary fibrosis through the succinate/SUCNR1 axis.

Rishi Rajesh, Agnes Anna Mooslechner, Hannah Schweighofer

|Mar 25, 2025
The molecular circadian clock of eosinophils: a potential therapeutic target for asthma.

Julia Teppan, Thomas Bärnthaler, Aitak Farzi

|Nov 25, 2023
HDL-Related Parameters and COVID-19 Mortality: The Importance of HDL Function.

Julia T Stadler, Hansjörg Habisch, Florian Prüller

|Nov 13, 2021
SUCNR1 Is Expressed in Human Placenta and Mediates Angiogenesis: Significance in Gestational Diabetes.

Reham Atallah, Juergen Gindlhuber, Wolfgang Platzer

Pageof 2